Delivery Order SPE2DB24D6039-SPE2DB25FLEAJ

Award Date 1/9/25
Potential Completion Date 1/10/25
Potential Value $1.5K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $5,204.31 firm fixed-price delivery order is for the supply of DAPAGLIFLOZIN 10 MG TABLET 30S, a medication used for diabetes management. The contract has an ultimate completion date of November 26, 2024. AmerisourceBergen holds a larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,884.08 fixed-price delivery order is for the supply of 4,566,448,537 units of Dapagliflozin 10 mg tablets, a medication used to treat type 2 diabetes. The contract has an ultimate completion date of November 18, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $7,074.18 firm fixed-price delivery order is for the supply of 4566736638 ! DAPAGLIFLOZIN 10 MG TABLET 30S, a medication used to treat diabetes. The contract has a ceiling value of $7,074.18 and an ultimate completion date of December 17, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,601.54 firm-fixed-price delivery order is for the supply of 4,566,150,890 units of the medication Dapagliflozin 10 mg tablets. The contract has an ultimate completion date of October 21, 2024 and was awarded on October 18, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $6,048.05 Firm Fixed Price Delivery Order is for the supply of 4565911283 Dapagliflozin 10 mg tablets, a medication used in the management of diabetes. The contract has an ultimate completion date of September 24, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
This federal contract award was issued by the Defense Logistics Agency Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,497.99 firm fixed-price delivery order is for the supply of DAPAGLIFLOZIN 10 MG TABLET 30S, a medication used to treat diabetes. The contract has an ultimate completion date of December 30, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract with the Defense Logistics...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $9,932.76 firm fixed price delivery order is for the supply of 4,566,177,485 dapagliflozin 10 mg tablets. The award has an ultimate completion date of October 23, 2024 and was made on October 22, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,995.58 firm fixed-price delivery order is for the supply of dapagliflozin 10 mg tablets, a medication used to manage diabetes. The contract has an ultimate completion date of December 16, 2024 and was awarded on December 13, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with...
This federal contract award from the Defense Logistics Agency (DLA) is a $2,116.01 firm fixed-price delivery order to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of 4,566,627,303 units of the prescription drug Dapagliflozin 10 mg tablets, which are used to treat type 2 diabetes. The contract has an ultimate completion date of December 6, 2024 and was awarded on December 5, 2024. AmerisourceBergen holds a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $21,737.17 Firm Fixed Price Delivery Order contract is for the supply of 4565768745 DAPAGLIFLOZIN 10 MG TABLET 30S, a diabetes medication. The contract has an ultimate completion date of September 12, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
  • SPE2DB24D6039
    Indefinite Delivery Contract
  • SPE2DB24D6039-SPE2DB25FLEAJ
    Delivery Order

This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,451.81 firm fixed-price delivery order covers the supply of 4566878224 - DAPAGLIFLOZIN 10 MG TABLET 30S, a medication used to manage diabetes. The contract has an ultimate completion date of January 10, 2025.

AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The company also maintains a separate $750,000 IDC with the Department of Justice Federal Bureau of Investigation for similar medical products and prescription drugs. These IDCs enable efficient government procurement of essential pharmaceutical and medical supplies for military personnel, veterans, and other federal beneficiaries.

Generated 4/13/25, 12:49 AM